Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

Photoreceptors and Visual Pathways

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Isolated intestinal manifestation of an invasive varicella zoster virus reactivation in an immunocompromised patient: a case report.

Acta gastro-enterologica Belgica·2024

Same author

Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.

Journal of neuro-oncology·2023

Same author

Spinal fluid evacuation may provide temporary relief for patients with unexplained widespread pain and fibromyalgia.

Medical hypotheses·2018

Same author

Fibromyalgia and unexplained widespread pain: The idiopathic cerebrospinal pressure dysregulation hypothesis.

Medical hypotheses·2018

Same author

Molecular Identification of Cutaneous Alternariosis in a Renal Transplant Patient.

Mycopathologia·2017

Same author

Late onset of Strongyloides stercoralis meningitis in a retired Belgian miner.

Acta clinica Belgica·2016

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Glaucoma medication during pregnancy and nursing.

G Coppens¹, I Stalmans, T Zeyen

¹UZ Leuven.

Bulletin De La Societe Belge D'Ophtalmologie

|May 20, 2010

Summary

Glaucoma medication risks to newborns are not well-established, but caution is advised during pregnancy and breastfeeding. Avoid most glaucoma drugs in the first trimester and specific types absolutely.

Area of Science:

Ophthalmology
Perinatology
Pharmacology

Background:

Glaucoma management requires balancing maternal vision health with potential fetal/neonatal risks.
Current evidence on the adverse effects of glaucoma medications on fetuses and neonates is limited.
Pregnancy and lactation necessitate careful consideration of ophthalmic drug safety.

Purpose of the Study:

To review the risks of glaucoma medications to the fetus and neonate.
To provide guidance on the safe use of glaucoma treatments during pregnancy and lactation.
To inform clinical decisions balancing maternal and infant health.

Main Methods:

Literature review of studies on glaucoma medications and pregnancy/lactation outcomes.
Analysis of existing evidence regarding teratogenicity and neonatal toxicity.

Related Experiment Videos

Last Updated: Jun 12, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Consultation of guidelines from organizations like the American Academy of Pediatrics.

Main Results:

No high-level evidence indicates significant harm to fetuses or neonates from glaucoma medications.
Avoidance of all topical and systemic glaucoma medications is recommended during the first trimester.
Systemic carbonic anhydrase inhibitors, topical prostaglandin analogs, and surgical antimetabolites should be strictly avoided.

Conclusions:

While evidence is limited, a precautionary approach to glaucoma medications during pregnancy is warranted.
Certain glaucoma medications pose higher risks and should be absolutely avoided.
Some topical agents may be compatible with lactation, but careful monitoring is essential.